D.E. Shaw & Co’s Artivion AORT Stock Holding History

D.E. Shaw & Co’s Portfolio AORT Stock Details AORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$239K	Buy	6,526 +1,370	+27%	+$54K	﹤0.01%	4151
2025 Q4	$235K	Buy	+5,156	New	+$230K	﹤0.01%	4266
2025 Q2	–	Sell	-24,523	Closed	-$603K	–	4327
2025 Q1	$603K	Sell	24,523 -6,002	-20%	-$167K	﹤0.01%	3392
2024 Q4	$873K	Sell	30,525 -4,507	-13%	-$125K	﹤0.01%	3277
2024 Q3	$933K	Sell	35,032 -11,368	-25%	-$295K	﹤0.01%	3326
2024 Q2	$1.19M	Sell	46,400 -9,452	-17%	-$212K	﹤0.01%	3070
2024 Q1	$1.18M	Sell	55,852 -45,751	-45%	-$852K	﹤0.01%	2978
2023 Q4	$1.82M	Buy	101,603 +34,985	+53%	+$544K	﹤0.01%	2744
2023 Q3	$1.01M	Sell	66,618 -28,623	-30%	-$463K	﹤0.01%	3050
2023 Q2	$1.64M	Buy	95,241 +42,088	+79%	+$620K	﹤0.01%	2762
2023 Q1	$696K	Buy	53,153 +6,070	+13%	+$77.6K	﹤0.01%	3383
2022 Q4	$571K	Buy	47,083 +18,452	+64%	+$222K	﹤0.01%	3780
2022 Q3	$396K	Sell	28,631 -38,780	-58%	-$781K	﹤0.01%	4180
2022 Q2	$1.27M	Sell	67,411 -5,986	-8%	-$115K	﹤0.01%	3461
2022 Q1	$1.57M	Sell	73,397 -49,098	-40%	-$948K	﹤0.01%	3539
2021 Q4	$2.49M	Sell	122,495 -44,612	-27%	-$900K	﹤0.01%	3148
2021 Q3	$3.73M	Sell	167,107 -8,203	-5%	-$211K	﹤0.01%	2405
2021 Q2	$4.98M	Buy	175,310 +52,744	+43%	+$1.44M	﹤0.01%	2045
2021 Q1	$2.77M	Sell	122,566 -33,097	-21%	-$810K	﹤0.01%	2304
2020 Q4	$3.67M	Buy	155,663 +39,238	+34%	+$795K	﹤0.01%	2108
2020 Q3	$2.15M	Buy	+116,425	New	+$2.23M	﹤0.01%	2347
2020 Q2	–	Sell	-15,057	Closed	-$255K	–	3967
2020 Q1	$255K	Buy	15,057 +1,775	+13%	+$45.5K	﹤0.01%	3547
2019 Q4	$360K	Sell	13,282 -7,239	-35%	-$178K	﹤0.01%	3552
2019 Q3	$557K	Sell	20,521 -4,443	-18%	-$126K	﹤0.01%	3161
2019 Q2	$747K	Buy	24,964 +17,185	+221%	+$510K	﹤0.01%	2848
2019 Q1	$227K	Sell	7,779 -1,875	-19%	-$53.5K	﹤0.01%	3345
2018 Q4	$274K	Sell	9,654 -2,034	-17%	-$61.2K	﹤0.01%	3399
2018 Q3	$411K	Sell	11,688 -8,008	-41%	-$258K	﹤0.01%	3214
2018 Q2	$549K	Sell	19,696 -12,463	-39%	-$314K	﹤0.01%	3061
2018 Q1	$645K	Buy	32,159 +6,966	+28%	+$133K	﹤0.01%	2762
2017 Q4	$482K	Sell	25,193 -8,157	-24%	-$163K	﹤0.01%	2999
2017 Q3	$757K	Sell	33,350 -25,215	-43%	-$508K	﹤0.01%	2671
2017 Q2	$1.17M	Buy	58,565 +16,784	+40%	+$301K	﹤0.01%	2316
2017 Q1	$696K	Sell	41,781 -22,216	-35%	-$392K	﹤0.01%	2551
2016 Q4	$1.23M	Sell	63,997 -48,662	-43%	-$887K	﹤0.01%	2333
2016 Q3	$1.98M	Buy	112,659 +7,282	+7%	+$110K	﹤0.01%	1931
2016 Q2	$1.25M	Sell	105,377 -11,641	-10%	-$137K	﹤0.01%	2273
2016 Q1	$1.26M	Buy	117,018 +11,964	+11%	+$122K	﹤0.01%	2207
2015 Q4	$1.13M	Buy	105,054 +9,763	+10%	+$102K	﹤0.01%	2558
2015 Q3	$927K	Buy	95,291 +19,881	+26%	+$208K	﹤0.01%	2651
2015 Q2	$851K	Buy	75,410 +4,607	+7%	+$49K	﹤0.01%	2822
2015 Q1	$734K	Buy	70,803 +4,861	+7%	+$53.6K	﹤0.01%	2789
2014 Q4	$747K	Sell	65,942 -19,519	-23%	-$202K	﹤0.01%	3053
2014 Q3	$844K	Sell	85,461 -50,738	-37%	-$499K	﹤0.01%	2950
2014 Q2	$1.22M	Sell	136,199 -16,593	-11%	-$153K	﹤0.01%	2753
2014 Q1	$1.52M	Sell	152,792 -21,243	-12%	-$218K	﹤0.01%	2651
2013 Q4	$1.93M	Sell	174,035 -14,128	-8%	-$133K	﹤0.01%	2563
2013 Q3	$1.32M	Sell	188,163 -33,395	-15%	-$226K	﹤0.01%	2792
2013 Q2	$1.39M	Buy	+221,558	New	+$1.35M	﹤0.01%	2448

Other funds holding AORT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

JIC

Juniper Investment Company New York $313M AUM 79.58% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

D.E. Shaw & Co's AORT Position: Q1 2026 in Review

D.E. Shaw & Co increased its Artivion (AORT) stake by 27% in Q1 2026, buying an estimated $54K and bringing the position to 6,526 shares worth $239K. The position accounts for ﹤0.01% of the portfolio, ranked #4151.

D.E. Shaw & Co first reported a position in AORT in Q2 2013 and has held it in 49 quarters since. The position peaked at $4.98M in Q2 2021. 239 funds tracked by Wall St. Rank hold AORT as of Q1 2026.

D.E. Shaw & Co held 6,526 shares of Artivion worth $239K as of Q1 2026.
D.E. Shaw & Co bought 1,370 Artivion shares in Q1 2026, an estimated $54K.
Artivion made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #4151 holding.
D.E. Shaw & Co first reported a position in Artivion in Q2 2013 and has held it in 49 quarters since.
D.E. Shaw & Co's Artivion position peaked at $4.98M in Q2 2021.
239 funds tracked by Wall St. Rank held Artivion as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.